Ontology for Symptomatic Treatment of Multiple Sclerosis
Abstract Objectives: Symptomatic treatment is an essential component in the overall treatment of multiple sclerosis (MS). However, knowledge in this regard is confusing and scattered. Physicians also have challenges in choosing symptomatic treatment based on the patient’s condition. To share, update, and reuse this knowledge, the aim of this study was to provide an ontology for MS symptomatic treatment. Methods: The Symptomatic Treatment of Multiple Sclerosis Ontology (STMSO) was developed according to Ontology Development 101 and a guideline for developing
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
